Repeated exposure to distressing content on social media platforms is linked to secondary trauma, anxiety, and emotional ...

NIPPON SHOKUBAI CO., LTD. headquartered in Osaka, Japan, has announced a plan to expand its GMP (*1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) ...